Work ScheduleStandard (Mon-Fri) Environmental ConditionsOffice Job Description Join Us as a Senior Country Approval Specialist - Make an Impact at the Forefront of Innovation The Senior Country Approval Specialist manages the preparation, review and coordination of
Country Study Startup Specialist (PART TIME) - Based in Bucharest - FSP Syneos Health® is a leading fully-integrated life sciences services organization built to accelerate customer success. We partner with innovators at every point across the drug development
About Protect Life Michigan Thousands of lives are on the line every day due to abortion. Are you ready to stand up and change hearts to stop it? We are defenders on a mission to recruit,
ResponsiveAds single packaged tag is a fundamentally simpler trafficking model than what publishers, agencies and DSPs are used to; one tag, all sizes, no re-trafficking. But getting there requires someone who understands both sides, the ResponsiveAds
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a
With a passion for life Join our diverse teams of passionate people and a career that allows you to develop both personally and professionally. At Getinge we exist to make life-saving technology accessible for more people.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a
Tulipについて 製造業は世界経済の約20%を占めながら、最もデジタル化が遅れている産業のひとつです。TulipはMITで創業した、製造現場の作業者のために設計されたAIネイティブ・ノーコードプラットフォームです。2026年1月には評価額13億ドルを達成し、前年比二桁成長を継続しています。世界経済フォーラムのGlobal InnovatorおよびGartner Leaderにも選出されています。 日本市場について 日本は世界第4位の製薬市場であり、世界でも特に高い製造基準を持つ国のひとつです。Tulipにとっても非常に重要な戦略市場と位置づけています。三菱電機からの戦略的出資を受け、DMG MORIとは長年にわたるパートナーシップを築いてきました。これらの関係は、私たちがこの市場に真剣に向き合っている証でもあります。 AstraZeneca、Eli Lilly、J&J、中外製薬といったグローバルなリーディングカンパニーがすでにTulipを導入し、電子バッチ記録・eDHR・ラインクリアランス・逸脱管理などの業務デジタル化を進めています。 今私たちが求めているのは、その土台の上に新たな成長を築いていける方です。このポジションは、日本の製薬・ライフサイエンス業界におけるセールスのPlaybookを自ら主体的に作っていただける方を募集しております。 勤務地は日本です。2026年はフルリモート勤務で、2027年にはオフィス開設を予定しています。なお、応募時点で有効な日本の就労ビザをお持ちであることが必須となります。ビザのスポンサーシップには対応しておりません。 About Tulip Manufacturing accounts for nearly 20% of the global economy yet remains one of the least digitized industries on earth. Tulip was founded at
Arcadis is the worlds leading company delivering sustainable design, engineering, and consultancy solutions for natural and built assets. We are more than 34,000 people, in over 30 countries, dedicated to improving quality of life. Everyone has
Career CategoryRegulatory Job Description Join Amgen’s Mission of Serving Patients At Amgen, if you feel like you’re part of something bigger, it’s because you are. Our shared mission—to serve patients living with serious illnesses—drives all that we
Rockwell Automation is a global technology leader focused on helping the world’s manufacturers be more productive, sustainable, and agile. With more than 28,000 employees who make the world better every day, we know we have something
Rockwell Automation is a global technology leader focused on helping the world’s manufacturers be more productive, sustainable, and agile. With more than 28,000 employees who make the world better every day, we know we have something
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a
Position Summary: The Graduate Program Coordinator in the School of Engineering at Vanderbilt University plays a central administrative and operational role in supporting the graduate programs in Chemical and Biomolecular Engineering and Interdisciplinary Materials Science. This
We appreciate your interest in employment with The Honest Company! The Honest Company is committed to a policy of equal employment opportunity, and will not discriminate against an applicant or employee on the basis of race,
Do you want to join a team where the mission is meaningful, the challenges are complex, and you can directly see the results of your hard work? Lundbeck is a global biopharmaceutical company focusing exclusively on